Developing new drugs is a complex and formidable challenge, intensified by rapidly evolving global health needs. De novo drug design is a promising strategy to accelerate and refine this process. The recent introduction of Generative Artificial Intelligence (AI) algorithms has brought new attention to the field and catalyzed a paradigm shift, allowing rapid and semi-automatic…
Frontiers in Hematology Template
Write in a clean editor, then format for Frontiers in Hematology in one click — DocuGuru applies the official Frontiers template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Frontiers in Hematology format
Frontiers in Hematology is a peer-reviewed journal published by Frontiers, covering Acute Myeloid Leukemia Research, Hemoglobinopathies and Related Disorders, Hematopoietic Stem Cell Transplantation. Over its lifetime it has published 196 papers, which have received 432 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Frontiers in Hematology. 2023;12(3):45–58.
Formats any DOI in Frontiers in Hematology style. No sign-up. |
| Publishes research in | Acute Myeloid Leukemia Research Hemoglobinopathies and Related Disorders Hematopoietic Stem Cell Transplantation Myeloproliferative Neoplasms: Diagnosis and Treatment CAR-T cell therapy research |
| ISSN | 2813-3935 |
| Citation impact (2-yr) | 1.83 |
| h-index | 11 |
| i10-index | 12 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | The Ohio State University |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Frontiers in Hematology per year
Citation impact of Frontiers in Hematology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Frontiers in Hematology
Sickle cell disease (SCD) is a genetic disorder caused by mutations in the β-globin chain of hemoglobin, leading to abnormal red blood cells, severe pain, anemia, organ damage, and increased infection risk. Inherited in an autosomal recessive manner, it mainly affects regions with high malaria incidence, like sub-Saharan Africa, the Middle East, and the Indian…
Beta thalassemia (β-thalassemia) is part of a group of inherited hemoglobinopathies caused by a mutation in the beta globin gene, leading to minimal functional hemoglobin and resulting in damaged red blood cells and anemia. β-Thalassemia is most common in the Mediterranean region, South-East Asia, the Indian subcontinent, and the Middle East. Many of these regions…
Background: after Nigeria, the Democratic Republic of Congo and India. The absence of well-described SCD cohorts is a major barrier to health research in SCD in Africa. Objective: This paper describes the Sickle Pan African Consortium (SPARCO) database in Tanzania, from the development, design of the study instruments, data collection, analysis of data and management…
Humanized mouse models with functional human genes, cells, and tissues are typically used for in vivo studies of diseases. Decades of studies on humanized mouse models have improved our understanding of hematopoiesis, infectious diseases, cancer biology, innate and adaptive immunity, and regenerative medicine. This review discusses the establishment and development of humanized mouse models and…